<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30541932</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>28</Day></DateCompleted><DateRevised><Year>2020</Year><Month>05</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1098-660X</ISSN><JournalIssue CitedMedium="Internet"><Volume>57</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of clinical microbiology</Title><ISOAbbreviation>J Clin Microbiol</ISOAbbreviation></Journal><ArticleTitle>Comprehensive Evaluation of Differential Serodiagnosis between Zika and Dengue Viral Infections.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e01506-18</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/JCM.01506-18</ELocationID><Abstract><AbstractText>Diagnostic testing for Zika virus (ZIKV) or dengue virus (DENV) infection can be accomplished by a nucleic acid detection method; however, a negative result does not exclude infection due to the low virus titer during infection depending on the timing of sample collection. Therefore, a ZIKV- or DENV-specific serological assay is essential for the accurate diagnosis of patients and to mitigate potential severe health outcomes. A retrospective study design with dual approaches of collecting human serum samples for testing was developed. All serum samples were extensively evaluated by using both noninfectious wild-type (wt) virus-like particles (VLPs) and soluble nonstructural protein 1 (NS1) in the standard immunoglobulin M (IgM) antibody-capture enzyme-linked immunosorbent assay (MAC-ELISA). Both ZIKV-derived wt-VLP- and NS1-MAC-ELISAs were found to have similar sensitivities for detecting anti-premembrane/envelope and NS1 antibodies from ZIKV-infected patient sera, although lower cross-reactivity to DENV2/3-NS1 was observed. Furthermore, group cross-reactive (GR)-antibody-ablated homologous fusion peptide-mutated (FP)-VLPs consistently showed higher positive-to-negative values than homologous wt-VLPs. Therefore, we used DENV-2/3 and ZIKV FP-VLPs to develop a novel, serological algorithm for differentiating ZIKV from DENV infection. Overall, the sensitivity and specificity of the FP-VLP-MAC-ELISA and the NS1-MAC-ELISA were each higher than 80%, with no statistical significance. The accuracy can reach up to 95% with the combination of FP-VLP and NS1 assays. In comparison to current guidelines using neutralization tests to measure ZIKV antibody, this approach can facilitate laboratory screening for ZIKV infection, especially in regions where DENV infection is endemic and capacity for neutralization testing does not exist.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chao</LastName><ForeName>Day-Yu</ForeName><Initials>DY</Initials><Identifier Source="ORCID">0000-0001-7139-026X</Identifier><AffiliationInfo><Affiliation>Graduate Institute of Microbiology and Public Health, College of Veterinary Medicine, National Chung-Hsing University, Taichung, Taiwan dychao@nchu.edu.tw gxc7@cdc.gov.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whitney</LastName><ForeName>Matthew T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>U.S. Department of Health and Human Services, Public Health Services, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davis</LastName><ForeName>Brent S</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>U.S. Department of Health and Human Services, Public Health Services, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Medina</LastName><ForeName>Freddy A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>U.S. Department of Health and Human Services, Public Health Services, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munoz</LastName><ForeName>Jorge L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>U.S. Department of Health and Human Services, Public Health Services, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Gwong-Jen J</ForeName><Initials>GJ</Initials><AffiliationInfo><Affiliation>U.S. Department of Health and Human Services, Public Health Services, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA dychao@nchu.edu.tw gxc7@cdc.gov.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>02</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Microbiol</MedlineTA><NlmUniqueID>7505564</NlmUniqueID><ISSNLinking>0095-1137</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017361">Viral Nonstructural Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003429" MajorTopicYN="N">Cross Reactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012698" MajorTopicYN="N">Serologic Tests</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017361" MajorTopicYN="N">Viral Nonstructural Proteins</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071244" MajorTopicYN="N">Zika Virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071243" MajorTopicYN="N">Zika Virus Infection</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ELISA</Keyword><Keyword MajorTopicYN="N">Zika virus</Keyword><Keyword MajorTopicYN="N">dengue virus</Keyword><Keyword MajorTopicYN="N">differential diagnosis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>12</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>12</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>12</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30541932</ArticleId><ArticleId IdType="pmc">PMC6425182</ArticleId><ArticleId IdType="doi">10.1128/JCM.01506-18</ArticleId><ArticleId IdType="pii">JCM.01506-18</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Musso D, Baud D, Gubler DJ. 2016. Zika virus. Clin Microbiol Infect 22:494&#x2013;496. doi:10.1016/j.cmi.2016.03.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2016.03.032</ArticleId><ArticleId IdType="pubmed">27067096</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins M, McGowan E, Jadi R, Young E, Lopez C, Baric R, Lazear H, de Silva A. 2017. Lack of durable cross-neutralizing antibodies against Zika virus from dengue virus infection. Emerg Infect Dis 23:773&#x2013;781. doi:10.3201/eid2305.161630.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2305.161630</ArticleId><ArticleId IdType="pmc">PMC5403059</ArticleId><ArticleId IdType="pubmed">28418292</ArticleId></ArticleIdList></Reference><Reference><Citation>Baud D, Gubler D, Schaub B, Lanteri M, Musso D. 2017. An update on Zika virus infection. Lancet 390:2099&#x2013;2109. doi:10.1016/S0140-6736(17)31450-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31450-2</ArticleId><ArticleId IdType="pubmed">28647173</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasmussen SA, Jamieson DJ, Honein MA, Petersen LR. 2016. Zika virus and birth defects: reviewing the evidence for causality. N Engl J Med 374:1981&#x2013;1987. doi:10.1056/NEJMsr1604338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsr1604338</ArticleId><ArticleId IdType="pubmed">27074377</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvet GA, Santos FB, Sequeira PC. 2016. Zika virus infection: epidemiology, clinical manifestations and diagnosis. Curr Opin Infect Dis 29:459&#x2013;466. doi:10.1097/QCO.0000000000000301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QCO.0000000000000301</ArticleId><ArticleId IdType="pubmed">27496713</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh R, Dhama K, Karthik K, Tiwari R, Khandia R, Munjal A, Iqbal H, Malik Y, Bueno-Mar&#xed; R. 2018. Advances in diagnosis, surveillance, and monitoring of Zika virus: an update. Front Microbiol 8:2677. doi:10.3389/fmicb.2017.02677.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2017.02677</ArticleId><ArticleId IdType="pmc">PMC5780406</ArticleId><ArticleId IdType="pubmed">29403448</ArticleId></ArticleIdList></Reference><Reference><Citation>Waggoner JJ, Pinsky BA. 2016. Zika virus: diagnostics for an emerging pandemic threat. J Clin Microbiol 54:860&#x2013;867. doi:10.1128/JCM.00279-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00279-16</ArticleId><ArticleId IdType="pmc">PMC4809954</ArticleId><ArticleId IdType="pubmed">26888897</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinz FX, Stiasny K. 2017. The antigenic structure of Zika virus and its relation to other flaviviruses: implications for infection and immunoprophylaxis. Microbiol Mol Biol Rev 81:e00055-16. doi:10.1128/MMBR.00055-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MMBR.00055-16</ArticleId><ArticleId IdType="pmc">PMC5312239</ArticleId><ArticleId IdType="pubmed">28179396</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejnirattisai W, Jumnainsong A, Onsirisakul N, Fitton P, Vasanawathana S, Limpitikul W, Puttikhunt C, Edwards C, Duangchinda T, Supasa S, Chawansuntati K, Malasit P, Mongkolsapaya J, Screaton G. 2010. Cross-reacting antibodies enhance dengue virus infection in humans. Science 328:745&#x2013;748. doi:10.1126/science.1185181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1185181</ArticleId><ArticleId IdType="pmc">PMC3837288</ArticleId><ArticleId IdType="pubmed">20448183</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapparapu G, Fernandez E, Kose N, Bin C, Fox J, Bombardi R, Zhao H, Nelson C, Bryan A, Barnes T, Davidson E, Mysorekar I, Fremont D, Doranz B, Diamond M, Crowe J. 2016. Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice. Nature 540:443&#x2013;447. doi:10.1038/nature20564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20564</ArticleId><ArticleId IdType="pmc">PMC5583716</ArticleId><ArticleId IdType="pubmed">27819683</ArticleId></ArticleIdList></Reference><Reference><Citation>Stettler K, Beltramello M, Espinosa D, Graham V, Cassotta A, Bianchi S, Vanzetta F, Minola A, Jaconi S, Mele F, Foglierini M, Pedotti M, Simonelli L, Dowall S, Atkinson B, Percivalle E, Simmons C, Varani L, Blum J, Baldanti F, Cameroni E, Hewson R, Harris E, Lanzavecchia A, Sallusto F, Corti D. 2016. Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science 353:823&#x2013;826. doi:10.1126/science.aaf8505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf8505</ArticleId><ArticleId IdType="pubmed">27417494</ArticleId></ArticleIdList></Reference><Reference><Citation>Calisher C, Karabatsos N, Dalrymple J, Shope R, Porterfield J, Westaway E, Brandt W. 1989. Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. J Gen Virol 70:37&#x2013;43. doi:10.1099/0022-1317-70-1-37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-70-1-37</ArticleId><ArticleId IdType="pubmed">2543738</ArticleId></ArticleIdList></Reference><Reference><Citation>Priyamvada L, Quicke K, Hudson W, Onlamoon N, Sewatanon J, Edupuganti S, Pattanapanyasat K, Chokephaibulkit K, Mulligan M, Wilson P, Ahmed R, Suthar M, Wrammert J. 2016. Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus. Proc Natl Acad Sci U S A 113:7852&#x2013;7857. doi:10.1073/pnas.1607931113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1607931113</ArticleId><ArticleId IdType="pmc">PMC4948328</ArticleId><ArticleId IdType="pubmed">27354515</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbiani D, Bozzacco L, Keeffe J, Khouri R, Olsen P, Gazumyan A, Schaefer-Babajew D, Avila-Rios S, Nogueira L, Patel R, Azzopardi S, Uhl L, Saeed M, Sevilla-Reyes E, Agudelo M, Yao K, Golijanin J, Gristick H, Lee Y, Hurley A, Caskey M, Pai J, Oliveira T, Wunder EJ, Sacramento G, Nery NJ, Orge C, Costa F, Reis M, Thomas N, Eisenreich T, Weinberger D, de Almeida A, West AJ, Rice C, Bjorkman P, Reyes-Teran G, Ko A, MacDonald M, Nussenzweig M. 2017. Recurrent potent human neutralizing antibodies to Zika virus in Brazil and Mexico. Cell 169:597&#x2013;609. doi:10.1016/j.cell.2017.04.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.04.024</ArticleId><ArticleId IdType="pmc">PMC5492969</ArticleId><ArticleId IdType="pubmed">28475892</ArticleId></ArticleIdList></Reference><Reference><Citation>Balmaseda A, Stettler K, Medialdea-Carrera R, Collado D, Jin X, Zambrana J, Jaconi S, Cameroni E, Saborio S, Rovida F, Percivalle E, Ijaz S, Dicks S, Ushiro-Lumb I, Barzon L, Siqueira P, Brown D, Baldanti F, Tedder R, Zambon M, de Filippis A, Harris E, Corti D. 2017. Antibody-based assay discriminates Zika virus infection from other flaviviruses. Proc Natl Acad Sci U S A 114:8384&#x2013;8389. doi:10.1073/pnas.1704984114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1704984114</ArticleId><ArticleId IdType="pmc">PMC5547631</ArticleId><ArticleId IdType="pubmed">28716913</ArticleId></ArticleIdList></Reference><Reference><Citation>Granger D, Hilgart H, Misner L, Christensen J, Bistodeau S, Palm J, Strain AK, Konstantinovski M, Liu D, Tran A, Theel ES. 2017. Serologic testing for Zika virus: comparison of three Zika virus IgM-screening enzyme-linked immunosorbent assays and initial laboratory experiences. J Clin Microbiol 55:2127&#x2013;2136. doi:10.1128/JCM.00580-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00580-17</ArticleId><ArticleId IdType="pmc">PMC5483914</ArticleId><ArticleId IdType="pubmed">28446573</ArticleId></ArticleIdList></Reference><Reference><Citation>Safronetz D, Sloan A, Stein D, Mendoza E, Barairo N, Ranadheera C, Scharikow L, Holloway K, Robinson A, Traykova-Andonova M, Makowski K, Dimitrova K, Giles E, Hiebert J, Mogk R, Beddome S, Drebot M. 2017. Evaluation of five commercially available Zika virus immunoassays. Emerg Infect Dis 23:1577&#x2013;1580. doi:10.3201/eid2309.162043.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2309.162043</ArticleId><ArticleId IdType="pmc">PMC5572859</ArticleId><ArticleId IdType="pubmed">28665268</ArticleId></ArticleIdList></Reference><Reference><Citation>Theel ES, Hata DJ. 2018. Diagnostic testing for Zika virus: a postoutbreak update. J Clin Microbiol 56:e01972-17. doi:10.1128/JCM.01972-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01972-17</ArticleId><ArticleId IdType="pmc">PMC5869840</ArticleId><ArticleId IdType="pubmed">29386264</ArticleId></ArticleIdList></Reference><Reference><Citation>Hennessey M, Fischer M, Staples JE. 2016. Zika virus spreads to new areas: region of the Americas, May 2015&#x2013;January 2016. MMWR Morb Mortal Wkly Rep 65:55&#x2013;58. doi:10.15585/mmwr.mm6503e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6503e1</ArticleId><ArticleId IdType="pubmed">26820163</ArticleId></ArticleIdList></Reference><Reference><Citation>Oduyebo T, Polen K, Walke H, Reagan-Steiner S, Lathrop E, Rabe I, Kuhnert-Tallman W, Martin S, Walker A, Gregory C, Ades E, Carroll D, Rivera M, Perez-Padilla J, Gould C, Nemhauser J, Ben BC, Harcourt J, Viens L, Johansson M, Ellington S, Petersen E, Smith L, Reichard J, Munoz-Jordan J, Beach M, Rose D, Barzilay E, Noonan-Smith M, Jamieson D, Zaki S, Petersen L, Honein M, Meaney-Delman D. 2017. Update: interim guidance for health care providers caring for pregnant women with possible Zika virus exposure: United States (including U.S. Territories), July 2017. MMWR Morb Mortal Wkly Rep 66:781&#x2013;793. doi:10.15585/mmwr.mm6629e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6629e1</ArticleId><ArticleId IdType="pmc">PMC5657812</ArticleId><ArticleId IdType="pubmed">28749921</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindsey NP, Staples JE, Powell K, Rabe IB, Fischer M, Powers AM, Kosoy OI, Mossel EC, Munoz-Jordan JL, Beltran M, Hancock WT, Toews K-AE, Ellis EM, Ellis BR, Panella AJ, Basile AJ, Calvert AE, Laven J, Goodman CH, Gould CV, Martin SW, Thomas JD, Villanueva J, Mataia ML, Sciulli R, Gose R, Whelen AC, Hills SL. 2017. Ability to serologically confirm recent Zika virus infection in areas with varying past incidence of dengue virus infection in the United States and U.S. territories in 2016. J Clin Microbiol 56:e01115-17. doi:10.1128/JCM.01115-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01115-17</ArticleId><ArticleId IdType="pmc">PMC5744200</ArticleId><ArticleId IdType="pubmed">29093104</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabe I, Staples J, Villanueva J, Hummel K, Johnson J, Rose L, Hills S, Wasley A, Fischer M, Powers A. 2016. Interim guidance for interpretation of Zika virus antibody test results. MMWR Morb Mortal Wkly Rep 65:543&#x2013;546. doi:10.15585/mmwr.mm6521e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6521e1</ArticleId><ArticleId IdType="pubmed">27254248</ArticleId></ArticleIdList></Reference><Reference><Citation>Bossuyt P, Reitsma J, Bruns D, Gatsonis C, Glasziou P, Irwig L, Lijmer J, Moher D, Rennie D, de Vet H, Kressel H, Rifai N, Golub R, Altman D, Hooft L, Korevaar D, Cohen J, STARD Group. 2015. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ 351:h5527. doi:10.1136/bmj.h5527.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.h5527</ArticleId><ArticleId IdType="pmc">PMC4623764</ArticleId><ArticleId IdType="pubmed">26511519</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao D-Y, Galula JU, Shen W-F, Davis BS, Chang G-JJ. 2015. Nonstructural protein 1-specific immunoglobulin M and G antibody capture enzyme-linked immunosorbent assays in diagnosis of flaviviral infections in humans. J Clin Microbiol 53:557&#x2013;566. doi:10.1128/JCM.02735-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.02735-14</ArticleId><ArticleId IdType="pmc">PMC4298564</ArticleId><ArticleId IdType="pubmed">25502522</ArticleId></ArticleIdList></Reference><Reference><Citation>Galula JU, Chang G-JJ, Chuang S-T, Chao D-Y. 2016. Establishment of an algorithm using prM/E- and NS1-specific IgM antibody-capture enzyme-linked immunosorbent assays in diagnosis of Japanese encephalitis virus and West Nile virus infections in humans. J Clin Microbiol 54:412&#x2013;422. doi:10.1128/JCM.02469-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.02469-15</ArticleId><ArticleId IdType="pmc">PMC4733197</ArticleId><ArticleId IdType="pubmed">26659204</ArticleId></ArticleIdList></Reference><Reference><Citation>Crill W, Hughes H, Delorey M, Chang G. 2009. Humoral immune responses of dengue fever patients using epitope-specific serotype-2 virus-like particle antigens. PLoS One 4:e4991. doi:10.1371/journal.pone.0004991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0004991</ArticleId><ArticleId IdType="pmc">PMC2659788</ArticleId><ArticleId IdType="pubmed">19337372</ArticleId></ArticleIdList></Reference><Reference><Citation>Huzly D, Hanselmann I, Schmidt-Chanasit J, Panning M. 2016. High specificity of a novel Zika virus ELISA in European patients after exposure to different flaviviruses. Euro Surveill 21:pii30203.</Citation><ArticleIdList><ArticleId IdType="pubmed">27126052</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai W, Youn H, Brites C, Tsai J, Tyson J, Pedroso C, Drexler J, Stone M, Simmons G, Busch M, Lanteri M, Stramer S, Balmaseda A, Harris E, Wang W. 2017. Distinguishing secondary dengue virus infection from Zika virus infection with previous dengue by a combination of three simple serological tests. Clin Infect Dis 65:1829&#x2013;1836. doi:10.1093/cid/cix672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cix672</ArticleId><ArticleId IdType="pmc">PMC5850648</ArticleId><ArticleId IdType="pubmed">29020159</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong S, Furuya A, Zou J, Xie X, Dupuis AI, Kramer L, Shi P. 2017. A multiplex microsphere immunoassay for Zika virus diagnosis. EBioMedicine 16:136&#x2013;140. doi:10.1016/j.ebiom.2017.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2017.01.008</ArticleId><ArticleId IdType="pmc">PMC5474433</ArticleId><ArticleId IdType="pubmed">28094237</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B, Pinsky B, Ananta J, Zhao S, Arulkumar S, Wan H, Sahoo M, Abeynayake J, Waggoner J, Hopes C, Tang M, Dai H. 2017. Diagnosis of Zika virus infection on a nanotechnology platform. Nat Med 23:548&#x2013;550. doi:10.1038/nm.4302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4302</ArticleId><ArticleId IdType="pubmed">28263312</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes DA, Purdy DE, Chao D-Y, Noga AJ, Chang G-JJ. 2005. Comparative analysis of immunoglobulin M (IgM) capture enzyme-linked immunosorbent assay using virus-like particles or virus-infected mouse brain antigens to detect IgM antibody in sera from patients with evident flaviviral infections. J Clin Microbiol 43:3227&#x2013;3236. doi:10.1128/JCM.43.7.3227-3236.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.43.7.3227-3236.2005</ArticleId><ArticleId IdType="pmc">PMC1169144</ArticleId><ArticleId IdType="pubmed">16000440</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberson JA, Crill WD, Chang G-JJ. 2007. Differentiation of West Nile and St. Louis encephalitis virus infections by use of noninfectious virus-like particles with reduced cross-reactivity. J Clin Microbiol 45:3167&#x2013;3174. doi:10.1128/JCM.01143-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01143-07</ArticleId><ArticleId IdType="pmc">PMC2045342</ArticleId><ArticleId IdType="pubmed">17715375</ArticleId></ArticleIdList></Reference><Reference><Citation>Rockstroh A, Moges B, Barzon L, Sinigaglia A, Pal&#xf9; G, Kumbukgolla W, Schmidt-Chanasit J, Sarno M, Brites C, Moreira-Soto A, Drexler J, Ferreira O, Ulbert S. 2017. Specific detection of dengue and Zika virus antibodies using envelope proteins with mutations in the conserved fusion loop. Emerg Microbes Infect 6:e99. doi:10.1038/emi.2017.87.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emi.2017.87</ArticleId><ArticleId IdType="pmc">PMC5717088</ArticleId><ArticleId IdType="pubmed">29116222</ArticleId></ArticleIdList></Reference><Reference><Citation>Crill W, Hughes H, Trainor N, Davis B, Whitney M, Chang G. 2012. Sculpting humoral immunity through dengue vaccination to enhance protective immunity. Front Immunol 3:334. doi:10.3389/fimmu.2012.00334.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2012.00334</ArticleId><ArticleId IdType="pmc">PMC3492872</ArticleId><ArticleId IdType="pubmed">23162552</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes H, Crill W, Chang G. 2012. Manipulation of immunodominant dengue virus E protein epitopes reduces potential antibody-dependent enhancement. Virol J 9:115. doi:10.1186/1743-422X-9-115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-9-115</ArticleId><ArticleId IdType="pmc">PMC3424142</ArticleId><ArticleId IdType="pubmed">22709350</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra N, Caciula A, Price A, Thakkar R, Ng J, Chauhan LV, Jain K, Che X, Espinosa DA, Montoya Cruz M, Balmaseda A, Sullivan EH, Patel JJ, Jarman RG, Rakeman JL, Egan CT, Reusken CBEM, Koopmans MPG, Harris E, Tokarz R, Briese T, Lipkin WI. 2018. Diagnosis of Zika virus infection by peptide array and enzyme-linked immunosorbent assay. mBio 9:e00095-18. doi:10.1128/mBio.00095-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00095-18</ArticleId><ArticleId IdType="pmc">PMC5844993</ArticleId><ArticleId IdType="pubmed">29511073</ArticleId></ArticleIdList></Reference><Reference><Citation>Premkumar L, Collins M, Graham S, Liou G-JA, Lopez CA, Jadi R, Balmaseda A, Brackbill JA, Dietze R, Camacho E, De Silva AD, Giuberti C, dos Reis HL, Singh T, Heimsath H, Weiskopf D, Sette A, Osorio JE, Permar SR, Miley MJ, Lazear HM, Harris E, de Silva AM. 2018. Development of envelope protein antigens to serologically differentiate Zika virus infection from dengue virus infection. J Clin Microbiol 56:e01504-17. doi:10.1128/JCM.01504-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01504-17</ArticleId><ArticleId IdType="pmc">PMC5824056</ArticleId><ArticleId IdType="pubmed">29263206</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown W, Akey D, Konwerski J, Tarrasch J, Skiniotis G, Kuhn R, Smith J. 2016. Extended surface for membrane association in Zika virus NS1 structure. Nat Struct Mol Biol 23:865&#x2013;867. doi:10.1038/nsmb.3268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.3268</ArticleId><ArticleId IdType="pmc">PMC5951387</ArticleId><ArticleId IdType="pubmed">27455458</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X, Song H, Qi J, Liu Y, Wang H, Su C, Shi Y, Gao G. 2016. Contribution of intertwined loop to membrane association revealed by Zika virus full-length NS1 structure. EMBO J 35:2170&#x2013;2178. doi:10.15252/embj.201695290.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201695290</ArticleId><ArticleId IdType="pmc">PMC5069551</ArticleId><ArticleId IdType="pubmed">27578809</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#x2019;Huillier AG, Hamid-Allie A, Kristjanson E, Papageorgiou L, Hung S, Wong CF, Stein DR, Olsha R, Goneau LW, Dimitrova K, Drebot M, Safronetz D, Gubbay JB. 2017. Evaluation of Euroimmun anti-Zika virus IgM and IgG enzyme-linked immunosorbent assays for Zika virus serologic testing. J Clin Microbiol 55:2462&#x2013;2471. doi:10.1128/JCM.00442-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00442-17</ArticleId><ArticleId IdType="pmc">PMC5527425</ArticleId><ArticleId IdType="pubmed">28566316</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinhagen K, Probst C, Radzimski C, Schmidt-Chanasit J, Emmerich P, van Esbroeck M, Schinkel J, Grobusch M, Goorhuis A, Warnecke J, Lattwein E, Komorowski L, Deerberg A, Saschenbrecker S, St&#xf6;cker W, Schlumberger W. 2016. Serodiagnosis of Zika virus (ZIKV) infections by a novel NS1-based ELISA devoid of cross-reactivity with dengue virus antibodies: a multicohort study of assay performance, 2015 to 2016. Euro Surveill 21:30426. doi:10.2807/1560-7917.ES.2016.21.50.30426.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2016.21.50.30426</ArticleId><ArticleId IdType="pmc">PMC5291135</ArticleId><ArticleId IdType="pubmed">28006649</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>